TMEM177 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.202000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.060400E-01
Normal-vs-Stage2
8.140400E-01
Normal-vs-Stage3
6.518600E-01
Normal-vs-Stage4
3.150400E-01
Stage1-vs-Stage2
1.187420E-01
Stage1-vs-Stage3
1.386590E-01
Stage1-vs-Stage4
6.605200E-01
Stage2-vs-Stage3
3.392600E-01
Stage2-vs-Stage4
4.351600E-02
Stage3-vs-Stage4
1.712570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.493000E-01
Normal-vs-AfricanAmerican
6.166600E-01
Normal-vs-Asian
3.257600E-01
Caucasian-vs-AfricanAmerican
6.991200E-01
Caucasian-vs-Asian
7.151900E-02
AfricanAmerican-vs-Asian
4.859400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.975400E-01
Normal-vs-Female
7.487600E-01
Male-vs-Female
9.321600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.498800E-01
Normal-vs-Age(41-60Yrs)
7.940800E-01
Normal-vs-Age(61-80Yrs)
7.616400E-01
Normal-vs-Age(81-100Yrs)
3.002000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.623600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.986400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.057000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.363600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.854100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.342960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.220800E-01
Normal-vs-Daily Drinker
7.676000E-01
Normal-vs-Weekly Drinker
5.331200E-01
Normal-vs-Occasional Drinker
3.243400E-01
Normal-vs-Social Drinker
4.747600E-01
Non Drinker-vs-Daily Drinker
4.133200E-01
Non Drinker-vs-Weekly Drinker
3.522800E-01
Non Drinker-vs-Occasional Drinker
7.094300E-02
Non Drinker-vs-Social Drinker
2.908800E-01
Daily Drinker-vs-Weekly Drinker
1.027560E-01
Daily Drinker-vs-Occasional Drinker
1.421650E-02
Daily Drinker-vs-Social Drinker
7.349500E-02
Weekly Drinker-vs-Occasional Drinker
4.540800E-01
Weekly Drinker-vs-Social Drinker
9.353800E-01
Occasional Drinker-vs-Social Drinker
4.806600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.289000E-01
Normal-vs-Grade 2
2.604200E-01
Normal-vs-Grade 3
1.734440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.759600E-01
Grade 1-vs-Grade 3
2.539600E-01
Grade 1-vs-Grade 4
5.289000E-01
Grade 2-vs-Grade 3
4.556200E-01
Grade 2-vs-Grade 4
2.604200E-01
Grade 3-vs-Grade 4
1.734440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.857800E-01
Normal-vs-NonDiabetic
5.592400E-01
Diabetic-vs-NonDiabetic
2.231900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.098800E-01
Normal-vs-NoPancreatitis
6.522600E-01
Pancreatitis-vs-NoPancreatitis
7.961600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.678000E-01
Normal-vs-N1
8.487800E-01
N0-vs-N1
3.326500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.427390E-01
Normal-vs-TP53-NonMutant
6.072600E-01
TP53-Mutant-vs-TP53-NonMutant
1.162370E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
